Frequently asked questions

A proprietary phytochemical composition derived from turmeric rhizome (Curcuma longa). It delivers upto 95% curcuminoids in a fully water-dispersible format, researched for joint comfort, mobility, cartilage support and healthy inflammatory balance.

Upto 95% total curcuminoids. The final analytical method appears on the current approved product specification and certificate of analysis.

Generic curcumin extracts have very low water dispersibility and limited oral absorption. Turmimax® BIO combines high curcuminoid purity with rapid water dispersion, prolonged dispersion stability, up to 35× higher bioavailability than standard curcumin, clinical research and patent protection.

It is described in the research materials as 100% water dispersible - it distributes effectively in water-based systems. It should not be described as completely water soluble unless supported by the approved technical specification.

Turmimax® BIO is standardised to total curcuminoids: curcumin, demethoxycurcumin and bisdemethoxycurcumin. Individual assay values should be taken from the current specification or batch COA.

Yes. India Patent No. 404286 is granted. US Application 16/995,834, PCT/IB2021/050750 and EP 21186828.6 are also on file.

The 2025 clinical presentation identifies a dose of 200 mg daily for 84 days. Final recommended use level must be confirmed against the signed clinical study protocol before publication.

In the 84-day study, improvements in total WOMAC score were already observed at Day 42 and continued through Day 84. Results can vary by formulation, serving level, consumer profile and consistency of use.

Improvements in WOMAC (pain, stiffness, difficulty), VAS scores and inflammatory/cartilage biomarkers including IL-6, Leukotriene B4, MMP-3, ESR and hs-CRP.

100 adults with mild-to-moderate knee osteoarthritis, in a 12-week prospective, randomized, double-blind, placebo-controlled design.

Preclinical osteoarthritis models found reductions in knee swelling and cartilage degradation and support for COL2A1, aggrecan and matrix markers with reduced MMP expression.

The supplied research reports Turmimax® BIO at approximately 35× the bioavailability of standard curcumin, with rapid and sustained dispersion.

Reported as well tolerated during the 84-day human study with no serious adverse events. Acute animal toxicology reported no deaths or acute toxic symptoms at 2,000 mg/kg body weight.

No serious adverse events were reported in the supplied clinical study. Individual responses may vary; finished-product labels should advise consumers who are pregnant, nursing, taking medication or managing a condition to consult a healthcare professional.

Regulatory suitability depends on ingredient classification, intended use, dosage, claim wording and product category. Local regulatory assessment is required per market.

Yes - the water-dispersible format is suited to evaluation in beverages, functional shots, drink powders and sachets. Finished-product testing should verify dispersion, flavour, colour, sedimentation, pH compatibility and stability.

Yes. Processing temperature, moisture exposure, excipient compatibility and finished-product stability should be validated per application.

A verified maximum processing temperature is not included in the supplied attachments. Heat stability should be confirmed via application testing or a current technical stability document.

The finished product should provide the confirmed clinically studied daily amount (200 mg per the 2025 report; final level to be confirmed by scientific and regulatory teams before launch).

It may be used standalone or combined in joint-comfort, mobility, sports-recovery and active-ageing stacks. Compatibility and claim substantiation should be evaluated for the complete formula.

MOQ can vary by grade, destination, packaging and commercial requirements. Contact the Star Hi Herbs sales team for the current Turmimax® BIO MOQ, quotation and lead time.

Yes. Qualified product developers, manufacturers and brand owners can submit a request. Sample quantity, courier arrangement and supporting documents will be confirmed by the commercial team.

Approved licensing partners may use the mark on qualifying finished products under a trademark licence agreement. See the trademark & licensing page for criteria and application.